Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 18;33(10):860.
doi: 10.1007/s00520-025-09919-3.

Symptom prevalence in gastrointestinal cancer: a secondary analysis of IPOS data

Elaine G Boland  1   2 , Assem Khamis  3 , Khek Tjian Tay  4 , Kathyrn Chater  5 , Paul Taylor  6 , Alison Landon  7 , Joy Ross  3   7 , Fliss E M Murtagh  3
Affiliations

Symptom prevalence in gastrointestinal cancer: a secondary analysis of IPOS data

Elaine G Boland et al. Support Care Cancer. .

Abstract

Purpose: Patients with gastro-intestinal (GI) cancer have a high symptom burden; however, comparative data to other cancers is lacking. The aim is to determine symptom prevalence for people with GI cancer receiving specialist palliative care in the community.

Method: Secondary analysis of anonymised routinely collected symptom registry data from those receiving community-based specialist palliative care, between 2020 and 2023.

Results: One thousand seven hundred thirty-three patients with GI cancer received 2,332 episodes of specialist palliative care. Common symptoms were: - pain (77% prevalence in GI cancer vs 73% other cancers); with 49% reporting being moderately/severely/overwhelmingly affected in GI vs 46% in other cancers. - nausea (34% in GI cancer vs 25% other cancers); with 16% moderately/severely/overwhelmingly affected in GI vs 11% in other cancers. - vomiting (17% in GI cancer vs 11% other cancers); with 8% moderately/severely/overwhelmingly affected in GI vs 5% in other cancers. - poor appetite (77% in GI cancer vs 68% other cancers); with 56% moderately/severely/overwhelmingly affected in GI vs 46% in other cancers. poor mobility (79% in GI cancer vs 84% other cancer); with 53% moderately/severely/overwhelmingly affected in GI vs 62% in other cancers.

Conclusion: This novel study provides comparative evidence about the nature of the high symptom burden for those with GI cancer and shows that poor appetite, nausea, vomiting, and worse mobility are more prevalent compared to other cancers, while pain and weakness are of similar prevalence. The underlying reasons may relate to illness trajectory, referral timing, or other causes and need further exploration.

Keywords: Community settings; Gastrointestinal cancer; IPOS; Specialist palliative care; Symptom prevalence.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Prevalence of IPOS symptoms and concerns in patients with GI cancer and all other cancers
See this image and copyright information in PMC

References

    1. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. 2019 [Available from: https://icd.who.int/browse10/2019/en
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249 - PubMed
    1. Cancer Statistics for the UK [Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics-f...
    1. Merchant SJ, Brogly SB, Booth CM, Goldie C, Nanji S, Patel SV et al (2019) Palliative care and symptom burden in the last year of life: a population-based study of patients with gastrointestinal cancer. Ann Surg Oncol 26(8):2336–2345 - PubMed
    1. Shin J, Kim SH, Suh SY, Cheng SY, Chen PJ, Yamaguchi T et al (2021) Physical and psychological symptoms and signs in dying digestive tract cancer patients: the East Asian collaborative cross-cultural study to elucidate the dying process (EASED). Support Care Cancer 29(7):3603–3612 - PubMed

LinkOut - more resources